ATYR
Price
$3.61
Change
-$0.14 (-3.73%)
Updated
Jan 17 closing price
Capitalization
303.03M
66 days until earnings call
MBCOF
Price
$0.10
Change
-$0.01 (-9.09%)
Updated
Jan 17 closing price
Capitalization
4.98M
Ad is loading...

ATYR vs MBCOF

Header iconATYR vs MBCOF Comparison
Open Charts ATYR vs MBCOFBanner chart's image
aTyr Pharma
Price$3.61
Change-$0.14 (-3.73%)
Volume$670.15K
Capitalization303.03M
MARVEL BIOSCIENCES
Price$0.10
Change-$0.01 (-9.09%)
Volume$16K
Capitalization4.98M
ATYR vs MBCOF Comparison Chart
Loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBCOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. MBCOF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Hold and MBCOF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ATYR: $3.61 vs. MBCOF: $0.10)
Brand notoriety: ATYR and MBCOF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 75% vs. MBCOF: 35%
Market capitalization -- ATYR: $303.03M vs. MBCOF: $4.98M
ATYR [@Biotechnology] is valued at $303.03M. MBCOF’s [@Biotechnology] market capitalization is $4.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileMBCOF’s FA Score has 1 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • MBCOF’s FA Score: 1 green, 4 red.
According to our system of comparison, MBCOF is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 5 TA indicator(s) are bullish while MBCOF’s TA Score has 3 bullish TA indicator(s).

  • ATYR’s TA Score: 5 bullish, 4 bearish.
  • MBCOF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ATYR is a better buy in the short-term than MBCOF.

Price Growth

ATYR (@Biotechnology) experienced а +2.27% price change this week, while MBCOF (@Biotechnology) price change was +2.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ATYR is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATYR($303M) has a higher market cap than MBCOF($4.98M). MBCOF YTD gains are higher at: 46.919 vs. ATYR (-0.276). MBCOF has higher annual earnings (EBITDA): -2.02M vs. ATYR (-66.11M). ATYR has more cash in the bank: 66M vs. MBCOF (83.3K). MBCOF has less debt than ATYR: MBCOF (1.71M) vs ATYR (13.6M). ATYR has higher revenues than MBCOF: ATYR (235K) vs MBCOF (0).
ATYRMBCOFATYR / MBCOF
Capitalization303M4.98M6,088%
EBITDA-66.11M-2.02M3,277%
Gain YTD-0.27646.919-1%
P/E RatioN/AN/A-
Revenue235K0-
Total Cash66M83.3K79,232%
Total Debt13.6M1.71M795%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATYRMBCOF
RSI
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
71%
Momentum
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
63%
MACD
ODDS (%)
Bullish Trend 12 days ago
90%
Bullish Trend 12 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 12 days ago
61%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 12 days ago
89%
Bearish Trend 12 days ago
55%
View a ticker or compare two or three
Ad is loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBCOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAECX17.940.13
+0.73%
Putnam Dynamic Asset Allocation Gr C
MMEYX47.380.29
+0.62%
Victory Integrity Discovery Y
BRUEX15.730.09
+0.58%
MFS Blended Research Value Equity B
MLCPX9.390.04
+0.43%
MainGate MLP C
OAKMX157.290.55
+0.35%
Oakmark Investor

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with FBIO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then FBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-3.73%
FBIO - ATYR
34%
Loosely correlated
-2.09%
VERV - ATYR
34%
Loosely correlated
+0.66%
MGTX - ATYR
33%
Loosely correlated
+5.56%
SER - ATYR
33%
Loosely correlated
+1.26%
CRSP - ATYR
33%
Poorly correlated
+0.57%
More

MBCOF and

Correlation & Price change

A.I.dvisor tells us that MBCOF and XENE have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBCOF and XENE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBCOF
1D Price
Change %
MBCOF100%
-5.54%
XENE - MBCOF
20%
Poorly correlated
-2.78%
AWKNF - MBCOF
20%
Poorly correlated
N/A
BSFAF - MBCOF
8%
Poorly correlated
N/A
ZEOX - MBCOF
6%
Poorly correlated
+0.35%
ATYR - MBCOF
5%
Poorly correlated
-3.73%
More